Specifically, GlaxoSmithKline notes that ???while the Group has no direct knowledge of the identity of its distributors??? downstream customers, it is possible that these customers include entities, such as government-owned hospitals and pharmacies, that are owned or controlled directly or indirectly by persons or entities sanctioned.??? Notable Disclosures by Industry In the world of Section 219